MAPP® Receives FDA 510(k) Clearance

Our MAPP® solution has received FDA 510(k) clearance, meaning that it can be marketed as a medical device in the United States.

This was a long process, completed in August, and will allow us to enter a highly developed market with significant potential.

We remain committed to our original goal of reaching more hospitals and helping ensure clinical safety for all patients receiving healthcare supported by our solutions.